3Bialecka M,Robowski P,Honczarenko K,et al.Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson's disease[J].Neurol Neurochir Pol,2009,43(3):272-285.
4Betarbet R,Sherer T B,Mackenzie G,et al.Chronic systemic pesticide exposure reproduces features of Parkinson's disease[J].Nat Neunosci,2000,3(12):1301-1306.
5Martin-Fernandez J J,Carles-Dies R,Canizares F,et al.Homocysteine and cognitive impairment in Parkinson's disease[J].Rev Neurol,2010,50(3):145-151.
6Rogets J D,Sanchez-Saffon A,Frol A B,et al.Elevated plasma homocysteine levels in patients treated with levodopa[J].Arch Neural,2003,60(1):59-64.
7Duan W,Ladenheim B,Cutler R G,et al.Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease[J].J Neurochem,2002,80(1):101-110.
8Zoccolella S,Aquila C,Abruzzese G,et al.Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia[J].Mov Disord,2009,24(7):1028-1033.
9Tolmunen T,Hintikka J,Voutilainen S,et al.Association between depressive symptoms and serum concentrations of homocysteine in men:a population study[J].Am J Clin Nutr,2004,80(6):1574-1578.
10Beydoun M A,Shroff M R,Beydoun H A,et al.Serum folate,Vitamin B-12,and homocysteine and their association with depressive symptoms among U.S.adults[J].Psychosom Med,2010,72(9):862-873.
8David A,Gallagher,Andrew J,et al.What are the most important non-motor symptoms in patients with parkinson's disease and are we missing them?[J].Mov Disord,2010,25:2493.
9Martinez-Martin P,Schapira AHV,Stocchi F,et al.Prevalence of non-motor symptoms in Parkinson's disease in an international setting;study using non-motor symptoms questionnaire in 545 patients[J].Mov Disord,2007,22:623.
10Braak H,Ghebremedhin E,Rüb U,et al.Stagesin the development of Parkinson's disease-related pathology[J].Cell and Tissue Research,2004,318:121.
